Piper Sandler Reiterates Overweight on CME Gr, Maintains $225 Price Target
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Patrick Moley has reiterated an Overweight rating on CME Group (NASDAQ:CME) and maintained a price target of $225.
August 20, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler analyst Patrick Moley has reiterated an Overweight rating on CME Group, maintaining a price target of $225. This suggests confidence in CME's stock performance.
The reiteration of an Overweight rating and a maintained price target of $225 by a reputable analyst suggests a positive outlook for CME Group's stock. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100